Intranodal palisaded myofibroblastoma

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Intranodal palisaded myofibroblastoma | |
|---|---|
| Synonyms | Intranodal hemorrhagic spindle cell tumor with amianthoid fibers |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Painless lymph node mass |
| Complications | Rarely, local recurrence |
| Onset | Typically in adults |
| Duration | Chronic |
| Types | N/A |
| Causes | Unknown |
| Risks | No known risk factors |
| Diagnosis | Histopathology |
| Differential diagnosis | Schwannoma, neurofibroma, leiomyoma |
| Prevention | N/A |
| Treatment | Surgical excision |
| Medication | N/A |
| Prognosis | Excellent with complete excision |
| Frequency | Rare |
| Deaths | N/A |
Intranodal palisaded myofibroblastoma (IPM), also known as intranodal hemorrhagic spindle-cell tumor with amianthoid fibers, is a rare, benign soft tissue tumor that typically arises within the lymph nodes. This neoplasm is characterized by the presence of spindle-shaped myofibroblasts, which are cells that play a key role in wound healing and are capable of contraction, similar to smooth muscle cells. The term "palisaded" refers to the arrangement of these cells in a pattern reminiscent of a palisade, while "amianthoid" fibers are thick, collagenous fibers found within the tumor, resembling asbestos fibers in appearance.
Etiology and Pathogenesis[edit]
The exact cause of IPM remains unknown. It is thought to arise from the myofibroblasts within the lymph node stroma. These cells can proliferate in response to various stimuli, possibly including trauma or inflammation, although no direct link has been established. The development of amianthoid fibers is considered a degenerative change, but its precise role in the pathogenesis of IPM is not fully understood.
Clinical Presentation[edit]
Patients with IPM typically present with a painless, slow-growing mass in the lymph nodes, most commonly located in the head and neck region, including the cervical lymph nodes. However, cases have been reported in other areas, such as the inguinal lymph nodes. The tumor affects adults predominantly, with no clear gender predilection.
Diagnosis[edit]
The diagnosis of IPM is primarily based on histopathological examination of the tumor. Imaging studies, such as ultrasound or computed tomography (CT) scans, may be used to assess the size and location of the mass but are not diagnostic. Histologically, IPM is characterized by spindle-shaped myofibroblasts arranged in a palisaded pattern, with interspersed amianthoid fibers. Immunohistochemistry may show positivity for smooth muscle actin (SMA), indicating the myofibroblastic nature of the cells.
Treatment and Prognosis[edit]
As IPM is a benign tumor, surgical excision is generally considered curative. There is a low risk of recurrence, especially if the tumor is completely removed. The prognosis for patients with IPM is excellent, with no known cases of malignant transformation or metastasis.
Epidemiology[edit]
IPM is a rare entity, with only a limited number of cases reported in the medical literature. Due to its rarity, the exact incidence and prevalence of the tumor are not known.
Summary[edit]
Intranodal palisaded myofibroblastoma is a rare, benign soft tissue tumor of the lymph nodes, characterized by the presence of spindle-shaped myofibroblasts and amianthoid fibers. The tumor has an excellent prognosis following surgical excision, with minimal risk of recurrence. Further research is needed to elucidate the etiology and pathogenesis of this unusual neoplasm.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian